InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Versant Venture Capital VII, L.P.. Officer active across 1 company, notably Chinook Therapeutics, INC.. Cumulatively, 5 filings have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €29m. Activity tracked since 27 August 2021. The latest transaction was filed on 4 April 2022 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
709,953 shares0Common StockSEC:0000899243-22-014108:0
600,000 shares@ US$16.000229.1% of flowCommon StockSEC:0000899243-22-000946
600,000 shares@ US$16.000229.1% of flowCommon StockSEC:0000899243-22-000946:0
510,000 shares@ US$14.0020.9% of flowCommon StockSEC:0000899243-21-034627:0
510,000 shares@ US$14.0020.9% of flowCommon StockSEC:0000899243-21-034627
5 of 5 declarations
About Versant Venture Capital VII, L.P.
Versant Venture Capital VII, L.P. is a director at Chinook Therapeutics, INC.
